Apheresis System - ANVISA Registration 10154450212
Access comprehensive regulatory information for Apheresis System in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10154450212 and manufactured by FRESENIUS KABI AG. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Jan 09, 2033.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including TERUMO BCT INC, HAEMONETICS CORPORATION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10154450212
25351478636202228
49601107000184
Company Information
Dates and Status
Jan 09, 2023
09/01/2033
09/18/2025 19:00:01
Sistema de Aferese
Sistema de Aférese NexSys PCS
HAEMONETICS CORPORATION
10234400328
Mar 24, 2025
Sistema de Aferese
Sistema de Aférese NexSys PCS
Not specified
10234400328
Mar 24, 2025
Sistema de Aferese
Sistema de Plasmaférese AURORA
Not specified
10154450213
Oct 02, 2023
Sistema de Aferese
Sistema de Plasmaférese AURORA
FRESENIUS KABI AG
10154450213
Oct 02, 2023
Sistema de Aferese
Mirasol Iluminador
TERUMO BCT INC
80554219006
Jun 19, 2023

